Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fagin

Showing results (111-120 of 261) with videos related to

Pageof 27
Sort By:
The American Journal of Pathology|December 1, 1996
Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasionT Nakayama, M Ito, A Ohtsuru, et al.
Cancer Research|April 3, 2003
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinomaEdna T Kimura, Marina N Nikiforova, Zhaowen Zhu, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 4, 1999
Growth hormone-insulin-like growth factor-I axis in adult insulin-dependent diabetic patients: evidence for central hypersensitivity to growth hormone-releasing hormone and peripheral resistance to growth hormoneP Fainstein Day, J A Fagin, R M Vaglio, et al.
Molecular Endocrinology (Baltimore, Md.)|April 12, 2003
Conditional expression of RET/PTC induces a weak oncogenic drive in thyroid PCCL3 cells and inhibits thyrotropin action at multiple levelsJianwei Wang, Jeffrey A Knauf, Saswata Basu, et al.
Molecular Endocrinology (Baltimore, Md.)|November 15, 2000
Conditional apoptosis induced by oncogenic ras in thyroid cellsJ M Shirokawa, R Elisei, J A Knauf, et al.
Endocrinology|February 13, 2001
Smooth muscle-targeted overexpression of insulin-like growth factor I results in enhanced vascular contractilityG Zhao, R L Sutliff, C S Weber, et al.
Circulation Research|April 1, 1994
Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cellsA Kamyar, C J Pirola, H M Wang, et al.
The Journal of Clinical Investigation|July 11, 2018
Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancersJeffrey A Knauf, Kathleen A Luckett, Kuen-Yuan Chen, et al.
Plos One|February 2, 2013
Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progressionMabel Ryder, Matti Gild, Tobias M Hohl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivoBin Ouyang, Jeffrey A Knauf, Eric P Smith, et al.
Pageof 27

Showing results (111-120 of 261) with videos related to

Sort By:
Pageof 27
The American Journal of Pathology|December 1, 1996
Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasionT Nakayama, M Ito, A Ohtsuru, et al.
Cancer Research|April 3, 2003
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinomaEdna T Kimura, Marina N Nikiforova, Zhaowen Zhu, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 4, 1999
Growth hormone-insulin-like growth factor-I axis in adult insulin-dependent diabetic patients: evidence for central hypersensitivity to growth hormone-releasing hormone and peripheral resistance to growth hormoneP Fainstein Day, J A Fagin, R M Vaglio, et al.
Molecular Endocrinology (Baltimore, Md.)|April 12, 2003
Conditional expression of RET/PTC induces a weak oncogenic drive in thyroid PCCL3 cells and inhibits thyrotropin action at multiple levelsJianwei Wang, Jeffrey A Knauf, Saswata Basu, et al.
Molecular Endocrinology (Baltimore, Md.)|November 15, 2000
Conditional apoptosis induced by oncogenic ras in thyroid cellsJ M Shirokawa, R Elisei, J A Knauf, et al.
Endocrinology|February 13, 2001
Smooth muscle-targeted overexpression of insulin-like growth factor I results in enhanced vascular contractilityG Zhao, R L Sutliff, C S Weber, et al.
Circulation Research|April 1, 1994
Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cellsA Kamyar, C J Pirola, H M Wang, et al.
The Journal of Clinical Investigation|July 11, 2018
Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancersJeffrey A Knauf, Kathleen A Luckett, Kuen-Yuan Chen, et al.
Plos One|February 2, 2013
Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progressionMabel Ryder, Matti Gild, Tobias M Hohl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivoBin Ouyang, Jeffrey A Knauf, Eric P Smith, et al.
Pageof 27